Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,058 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Endomicroscopy and Gastric MALT-lymphoma

NCT01583699

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology Vienna, Austria
View Trial Details
Completed

Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

NCT00618722

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Carina Heights, Australia
  • Investigational Site Gold Coast, Australia
  • Investigational Site Toorak, Australia
  • Investigational Site Oakville, Ontario, Canada
View Trial Details
Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

NCT01305577

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Oudenaarde, Minderbroederstaraat, Belgium
  • Investigational Site Arras, France
  • Investigational Site Cannes, France
  • Investigational Site Nice, France
View all 30 locations
View Trial Details
Completed

Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat

NCT00618618

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Toorak, Victoria, Australia
  • Investigational Site Sydney, Australia
  • Investigational Site Niagara Falls, Ontario, Canada
  • Investigational Site Oakville, Ontario, Canada
View Trial Details
Completed

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

NCT00469729

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +29 more
Locations
  • UCLA's Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • The Children's Hospital, B115, University of Colorado Health Sciences Center Aurora, Colorado, United States
  • Northwestern University School of Medicine, Stem Cell Transplant Program, Children's Memorial Hospital Chicago, Illinois, United States
View all 30 locations
View Trial Details
Completed

Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

NCT01403415

Conditions
Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia, Hematologic Diseases, +16 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 31 locations
View Trial Details
Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

NCT00413075

Conditions
Adenoma, Adenosarcoma, Adnexal Diseases, +89 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Columbia University - Herbert Irving Cancer Center New York, United States
  • New York University Cancer Institute New York, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions